Jan Burger, MD
Internal Medicine · Houston, TXNPI 1003901612
Payments from drug & device makers
Across 353 payments — averaging $133,905 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$16.9M
- Pharmacyclics LLC, An Abbvie Company$11.9M
- AbbVie$9M
- Beigene, Ltd.$7.8M
- Beone Medicines Ltd.$1.3M
- Beigene AUS Pty Ltd$136K
- plus $213K from 14 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 14 | $16,862,405 |
| Pharmacyclics LLC, An Abbvie Company | 30 | $11,949,960 |
| AbbVie | 26 | $8,975,940 |
| Beigene, Ltd. | 177 | $7,827,521 |
| Beone Medicines Ltd. | 28 | $1,303,801 |
| Beigene AUS Pty Ltd | 25 | $136,024 |
| Janssen Research & Development, LLC | 11 | $80,099 |
| Gilead | 3 | $50,000 |
| TG Therapeutics, Inc. | 8 | $35,890 |
| Beigene USA, Inc. | 3 | $23,665 |
| Johnson & Johnson | 7 | $10,001 |
| Janssen Global Services, LLC | 9 | $9,856 |
| CSL Behring | 2 | $2,731 |
| Genentech, Inc. | 1 | $150 |
| Sobi, Inc | 4 | $121 |
| Beone Medicines USA, Inc. | 1 | $120 |
| GSK | 1 | $24 |
| Astellas Pharma US Inc | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Azurity Pharmaceuticals, Inc. | 1 | $17 |
How this compares
$47,268,365 in reported general payments places this provider in the 95th percentile of 7,675 internal medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other internal medicine in Houston
- Nitin JainHouston$33.2M
- Aung NaingHouston$30.6M
- Preetesh JainHouston$19.5M
- Paolo StratiHouston$19.2M
- Nicholas ShortHouston$17.6M
- Isabella GlitzaHouston$14.8M
- Murtaza MussajiHouston$13.1M
- Hussein TawbiHouston$12.6M
- Hans LeeHouston$11.7M
- Dominick DaunnoHouston$11.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.